Assessment of tumor oxygenation and its impact on treatment response in bevacizumab-treated recurrent glioblastoma

Antiantiogenic therapy with bevacizumab in recurrent glioblastoma is currently understood to both reduce microvascular density and to prune abnormal tumor microvessels. Microvascular pruning and the resulting vascular normalization are hypothesized to reduce tumor hypoxia and increase supply of syst...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Cereb Blood Flow Metab
Hlavní autoři: Bonekamp, David, Mouridsen, Kim, Radbruch, Alexander, Kurz, Felix T, Eidel, Oliver, Wick, Antje, Schlemmer, Heinz-Peter, Wick, Wolfgang, Bendszus, Martin, Østergaard, Leif, Kickingereder, Philipp
Médium: Artigo
Jazyk:Inglês
Vydáno: SAGE Publications 2016
Témata:
Original Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5381446/
https://ncbi.nlm.nih.gov/pubmed/26861817
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0271678X16630322
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky